ArticleCancers2026

Real-World Treatment Patterns and Clinical Outcomes After First-Line Therapy in Patients with KRAS G12C-Mutant Advanced Non-Small-Cell Lung Cancer in the United States.

Kristin M Sheffield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.